CTVA vs SLRX · P/E 42, rev $16.91B vs $4.9M cap
Corteva Inc (CTVA) versus Salarius Pharmaceuticals Inc (SLRX) — a side-by-side from cached financials, not a winner call.
Corteva Inc (CTVA) is a agricultural inputs company listed on US.
Salarius Pharmaceuticals Inc (SLRX) is a biotechnology company listed on NASDAQ.
Latest reported CTVA revenue for 2024-12-31 was $16.91B. Net income was $919.0M. Revenue was down 1.8% from 2023-12-31 to 2024-12-31. CTVA currently screens at market cap $51.52B and trailing P/E 41.6.
Latest reported SLRX revenue for 2023-03-31 was $0. Net income was -$5.3M. SLRX currently screens at market cap $4.9M.
CTVA currently screens at market cap $51.52B and trailing P/E 41.6. SLRX currently screens at market cap $4.9M.
Not investment advice. Open the CTVA and SLRX stock pages for the full models.
Not investment advice.